IUPAC-induced computational approaches for identifying boosters of small biomolecule functionality: A case study of human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors

This paper introduces several proof-of-concept (PoC) computational methods intended to offer biochemical researchers straightforward, time- and cost-effective strategies to accelerate their work. While Machine Learning (ML) models were developed, the study's central purpose was to explore approaches for the identification of desirable functional groups/fragments in small biomolecules regarding a specific functionality, which, in this case, was human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibition. This was achieved primarily by tokenising IUPAC names to generate features. Additionally, the applicability of the CID_SID ML model for predicting TDP1 activity was developed and explored. Since these computational approaches were not experimentally validated due to a lack of appropriate laboratory facilities, they are presented as open proposals for further laboratory investigation.

Authors

Institutions

Publication Details

Journal
Computers in Biology and Medicine
Published
2026-02-05
DOI
https://doi.org/10.1016/j.compbiomed.2026.111531
Citations
1
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
45.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IUPAC-induced computational approaches for identifying boosters of small biomolecule functionality: A case study of human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors

Mariya L. Ivanova, Konstantin Nikolić, Nicola Russo, Gueorgui Mihaylov
1 citations
Computers in Biology and Medicine
Computational Drug Discovery Methods
45.17
article

IUPAC-induced computational approaches for identifying boosters of small biomolecule functionality: A case study of human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors

Mariya L. Ivanova, Konstantin Nikolić, Nicola Russo, Gueorgui Mihaylov
article en
1 citations

Abstract

This paper introduces several proof-of-concept (PoC) computational methods intended to offer biochemical researchers straightforward, time- and cost-effective strategies to accelerate their work. While Machine Learning (ML) models were developed, the study's central purpose was to explore approaches for the identification of desirable functional groups/fragments in small biomolecules regarding a specific functionality, which, in this case, was human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibition. This was achieved primarily by tokenising IUPAC names to generate features. Additionally, the applicability of the CID_SID ML model for predicting TDP1 activity was developed and explored. Since these computational approaches were not experimentally validated due to a lack of appropriate laboratory facilities, they are presented as open proposals for further laboratory investigation.

Computers in Biology and MedicineVol. 204
University of West London (GB), Halton General Hospital (GB)
Openalex Percentile: Top 1%
Computational Drug Discovery Methods
45.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.